BioAtla, Inc.
BCAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,778 | -$18,711 | -$15,334 | -$14,884 |
| Dep. & Amort. | $56 | $115 | $183 | $228 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1,645 | $1,931 |
| Change in WC | $1,414 | $2,802 | -$902 | -$3,251 |
| Other Non-Cash | $4,427 | $1,596 | -$1,880 | -$807 |
| Operating Cash Flow | -$9,881 | -$14,198 | -$16,288 | -$16,783 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $47 | $0 | $9,215 |
| Stock Repurch. | -$6 | $0 | -$29 | $98 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$5 | -$366 | $0 |
| Financing Cash Flow | -$6 | $42 | -$395 | $9,313 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,887 | -$14,156 | -$16,683 | -$7,470 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,207 | $32,363 | $49,046 | $56,516 |
| End Cash | $8,320 | $18,207 | $32,363 | $49,046 |
| Free Cash Flow | -$9,881 | $0 | -$16,288 | -$16,783 |